Nicholas K Hayward Selected Research

Cutaneous Malignant Melanoma

2/2015	Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
2/2010	Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma.
4/2009	Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma.
10/2006	High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
1/2004	Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas K Hayward Research Topics

Disease

93	Melanoma (Melanoma, Malignant) 10/2022 - 01/2002
47	Neoplasms (Cancer) 10/2022 - 07/2003
8	Nevus (Nevi) 07/2021 - 10/2004
6	Uveal melanoma 01/2020 - 10/2006
5	Lung Neoplasms (Lung Cancer) 01/2016 - 08/2010
5	Neoplasm Metastasis (Metastasis) 01/2016 - 06/2005
5	Cutaneous Malignant Melanoma 02/2015 - 01/2004
4	Schizophrenia (Dementia Praecox) 02/2009 - 08/2003
3	Carcinogenesis 01/2021 - 08/2010
3	Adenocarcinoma 09/2010 - 07/2010
3	Oculocutaneous albinism type 2 02/2010 - 02/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 12/2015
2	Inflammation (Inflammations) 10/2017 - 09/2003
2	Emphysema 01/2014 - 09/2009
2	Multiple Endocrine Neoplasia Type 1 06/2012 - 02/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012 - 09/2010
2	Adenocarcinoma of Lung 01/2012 - 08/2010
2	Retinoblastoma (Glioblastoma, Retinal) 08/2006 - 08/2005
1	Mesothelioma 01/2022
1	Circulating Neoplastic Cells 01/2021
1	Pigmented Nevus (Melanocytic Nevus) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Skin Neoplasms (Skin Cancer) 10/2017
1	Adenoma (Adenomas) 12/2015

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2003
16	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2003
10	MicroRNAs (MicroRNA)IBA 11/2019 - 03/2010
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2010
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020 - 03/2010
7	Biological ProductsIBA 10/2022 - 09/2009
7	Messenger RNA (mRNA)IBA 01/2018 - 02/2007
6	Nonsense Codon (Nonsense Mutation)IBA 07/2019 - 12/2008
6	Type 1 Melanocortin ReceptorIBA 08/2013 - 10/2008
5	Formaldehyde (Formol)FDA Link 01/2021 - 07/2003
5	Mitogen-Activated Protein KinasesIBA 11/2017 - 10/2002
4	Phosphotransferases (Kinase)IBA 07/2021 - 12/2014
4	ParaffinIBA 01/2021 - 07/2003
4	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2007 - 01/2002
3	EnzymesIBA 01/2022 - 02/2015
3	Histone MethyltransferasesIBA 01/2022 - 02/2004
3	NucleotidesIBA 07/2021 - 10/2008
3	Pharmaceutical PreparationsIBA 10/2019 - 01/2012
3	Codon (Codons)IBA 01/2019 - 09/2005
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 06/2011
3	RNA (Ribonucleic Acid)IBA 01/2017 - 09/2009
3	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2015 - 08/2010
3	Retinoblastoma ProteinIBA 07/2014 - 08/2006
3	Interferon Regulatory FactorsIBA 10/2011 - 02/2010
2	CateninsIBA 01/2021 - 10/2017
2	pembrolizumabIBA 07/2019 - 01/2019
2	IpilimumabIBA 07/2019 - 01/2019
2	Circulating Tumor DNAIBA 01/2019 - 10/2017
2	Valine (L-Valine)FDA Link 12/2018 - 09/2006
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 02/2015
2	Small Interfering RNA (siRNA)IBA 01/2017 - 12/2011
2	Peptides (Polypeptides)IBA 09/2015 - 05/2015
2	VemurafenibIBA 07/2015 - 01/2012
2	Cyclin-Dependent Kinase 4IBA 04/2015 - 02/2011
2	Shelterin ComplexIBA 02/2015 - 02/2015
2	trametinibIBA 01/2015 - 12/2014
2	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 02/2014 - 12/2011
2	Sunscreening Agents (Sunscreens)IBA 11/2013 - 09/2010
2	Microphthalmia-Associated Transcription FactorIBA 09/2013 - 11/2011
2	Amino Acids FDA Link 05/2012 - 09/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2012 - 09/2009
2	AsbestosIBA 01/2012 - 08/2010
2	CollagenIBA 01/2011 - 09/2003
2	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2010 - 02/2006
2	Vascular Endothelial Growth Factor BIBA 09/2003 - 08/2002
1	LigandsIBA 10/2022
1	MethyltransferasesIBA 01/2022
1	CrizotinibIBA 07/2021
1	Indicators and Reagents (Reagents)IBA 12/2020
1	S63845IBA 10/2020
1	Apoptosis Regulatory ProteinsIBA 10/2020
1	GSK1210151AIBA 10/2020
1	Circulating MicroRNAIBA 11/2019
1	DisulfidesIBA 12/2018
1	GTP Phosphohydrolases (GTPases)IBA 12/2018
1	Cysteine (L-Cysteine)FDA Link 12/2018
1	telomerase RNA (bTR)IBA 11/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 10/2017
1	Vitamin D FDA LinkGeneric 10/2017
1	GA-Binding Protein Transcription FactorIBA 01/2017
1	Proto-Oncogene Proteins c-etsIBA 01/2017
1	Biotin (Vitamin H)FDA Link 08/2016
1	Activating Transcription Factor 2IBA 01/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2016
1	Exonucleases (3' 5' Exonuclease)IBA 12/2015
1	EpitopesIBA 09/2015
1	LuciferasesIBA 07/2015
1	Ligases (Synthetase)IBA 06/2015
1	UbiquitinIBA 06/2015

Therapy/Procedure

18	Therapeutics 01/2022 - 09/2003
3	Immunotherapy 10/2022 - 10/2020
3	Drug Therapy (Chemotherapy) 12/2020 - 06/2005
2	Radiotherapy 01/2020 - 06/2005